Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Detection of pharmacovigilance-related adverse events using electronic health records and automated methods.

Haerian K, Varn D, Vaidya S, Ena L, Chase HS, Friedman C.

Clin Pharmacol Ther. 2012 Aug;92(2):228-34. doi: 10.1038/clpt.2012.54. Epub 2012 Jun 20.

2.

Pharmacovigilance in children in Camagüey Province, Cuba.

Bárzaga Arencibia Z, López Leyva A, Mejías Peña Y, González Reyes AR, Fernández Manzano E, Choonara I.

Eur J Clin Pharmacol. 2012 Jul;68(7):1079-84. doi: 10.1007/s00228-012-1222-9. Epub 2012 Feb 8.

3.

A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.

Coloma PM, Avillach P, Salvo F, Schuemie MJ, Ferrajolo C, Pariente A, Fourrier-Réglat A, Molokhia M, Patadia V, van der Lei J, Sturkenboom M, Trifirò G.

Drug Saf. 2013 Jan;36(1):13-23. doi: 10.1007/s40264-012-0002-x.

PMID:
23315292
4.

Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions.

Harpaz R, Vilar S, Dumouchel W, Salmasian H, Haerian K, Shah NH, Chase HS, Friedman C.

J Am Med Inform Assoc. 2013 May 1;20(3):413-9. doi: 10.1136/amiajnl-2012-000930. Epub 2012 Oct 31.

5.

A knowledge based approach for automated signal generation in pharmacovigilance.

Henegar C, Bousquet C, Lillo-Le Louët A, Degoulet P, Jaulent MC.

Stud Health Technol Inform. 2004;107(Pt 1):626-30.

PMID:
15360888
6.

Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.

Cederholm S, Hill G, Asiimwe A, Bate A, Bhayat F, Persson Brobert G, Bergvall T, Ansell D, Star K, Norén GN.

Drug Saf. 2015 Jan;38(1):87-100. doi: 10.1007/s40264-014-0251-y.

7.

[Knowledge creation about adverse drug reactions in the paediatric population].

Aagaard L.

Ugeskr Laeger. 2013 Feb 4;175(6):342-5. Danish.

PMID:
23402239
8.

A method for controlling complex confounding effects in the detection of adverse drug reactions using electronic health records.

Li Y, Salmasian H, Vilar S, Chase H, Friedman C, Wei Y.

J Am Med Inform Assoc. 2014 Mar-Apr;21(2):308-14. doi: 10.1136/amiajnl-2013-001718. Epub 2013 Aug 1.

9.

Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future.

Fabiano V, Mameli C, Zuccotti GV.

Expert Opin Drug Saf. 2012 Jan;11(1):95-105. doi: 10.1517/14740338.2011.584531. Epub 2011 May 9. Review.

PMID:
21548838
10.

Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?

Trifirò G, Pariente A, Coloma PM, Kors JA, Polimeni G, Miremont-Salamé G, Catania MA, Salvo F, David A, Moore N, Caputi AP, Sturkenboom M, Molokhia M, Hippisley-Cox J, Acedo CD, van der Lei J, Fourrier-Reglat A; EU-ADR group.

Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1176-84. doi: 10.1002/pds.1836.

PMID:
19757412
11.

The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection.

Wahab IA, Pratt NL, Wiese MD, Kalisch LM, Roughead EE.

Pharmacoepidemiol Drug Saf. 2013 May;22(5):496-502. doi: 10.1002/pds.3417. Epub 2013 Feb 14.

PMID:
23412832
12.

Data mining to generate adverse drug events detection rules.

Chazard E, Ficheur G, Bernonville S, Luyckx M, Beuscart R.

IEEE Trans Inf Technol Biomed. 2011 Nov;15(6):823-30. doi: 10.1109/TITB.2011.2165727. Epub 2011 Aug 22.

PMID:
21859604
13.

The EU-ADR Web Platform: delivering advanced pharmacovigilance tools.

Oliveira JL, Lopes P, Nunes T, Campos D, Boyer S, Ahlberg E, van Mulligen EM, Kors JA, Singh B, Furlong LI, Sanz F, Bauer-Mehren A, Carrascosa MC, Mestres J, Avillach P, Diallo G, Díaz Acedo C, van der Lei J.

Pharmacoepidemiol Drug Saf. 2013 May;22(5):459-67. doi: 10.1002/pds.3375. Epub 2012 Dec 4.

PMID:
23208789
14.

Longitudinal medical records as a complement to routine drug safety signal analysis.

Star K, Watson S, Sandberg L, Johansson J, Edwards IR.

Pharmacoepidemiol Drug Saf. 2015 May;24(5):486-94. doi: 10.1002/pds.3739. Epub 2015 Jan 27.

15.

Serious adverse drug reactions in older adults notified to pharmacovigilance.

Charfi R, El Aïdli S, Zaïem A, Kastalli S, Sraïri S, Daghfous R, Lakhal M.

Therapie. 2012 Sep-Oct;67(5):465-70. doi: 10.2515/therapie/2012060. Epub 2012 Dec 18.

PMID:
23241256
16.

Pharmacovigilance using clinical notes.

LePendu P, Iyer SV, Bauer-Mehren A, Harpaz R, Mortensen JM, Podchiyska T, Ferris TA, Shah NH.

Clin Pharmacol Ther. 2013 Jun;93(6):547-55. doi: 10.1038/clpt.2013.47. Epub 2013 Mar 4.

17.

Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine.

Fattinger K, Roos M, Vergères P, Holenstein C, Kind B, Masche U, Stocker DN, Braunschweig S, Kullak-Ublick GA, Galeazzi RL, Follath F, Gasser T, Meier PJ.

Br J Clin Pharmacol. 2000 Feb;49(2):158-67.

18.

Adverse drug reactions in older adults: a retrospective study from pharmacovigilance.

Charfi R, El Aïdli S, Zaïem A, Kastalli S, Sraïri S, Daghfous R, Lakhal M.

Therapie. 2012 Sep-Oct;67(5):471-6. doi: 10.2515/therapie/2012059. Epub 2012 Dec 18.

PMID:
23241257
19.

A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system.

Chen CJ, Cheng CF, Lin HY, Hung SP, Chen WC, Lin MS.

J Clin Pharm Ther. 2012 Dec;37(6):647-51. doi: 10.1111/j.1365-2710.2012.01359.x. Epub 2012 May 30.

PMID:
22646235
20.

Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.

Iaccheri B, Fiore T, Papadaki T, Androudi S, Janjua S, Bhaila I, Stephen Foster C.

Clin Ther. 2008 Nov;30(11):2069-74. doi: 10.1016/j.clinthera.2008.10.021.

PMID:
19108794

Supplemental Content

Support Center